A new study being presented at this year’s ACAAI Annual Scientific Meeting followed 5,874 kids with asthma in Los Angeles for 15 years and found no increase in allergic sensitizations.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año mostró que la mayoría de las mujeres embarazadas con una etiqueta de alergia a la penicilina a las que se les hizo la prueba no eran alérgicas y podían tolerar la penicilina durante el parto.
Un nuevo caso médicamente difícil presentado en la Reunión Científica Anual del ACAAI de este año informa de una situación en la que un medicamento antinflamatorio no esteroideo (AINE) causó una reacción anafiláctica en una maratonista.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la incorporación temprana del huevo está asociada con una menor probabilidad de tener alergia al huevo.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la población latina con asma tenían 4.6 veces más probabilidad que la población negra de presentar exacerbaciones del asma (asma no controlada) después de la COVID-19 y 2.9 veces más probabilidad que la población blanca.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la mayoría de los adultos encuestados no recibió preparación suficiente para su transición de parte de sus proveedores de la salud de asma infantil.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año hizo un seguimiento de 5874 niños con asma en Los Ángeles durante 15 años y descubrió que no hubo un aumento de las sensibilizaciones alérgicas.
Dos nuevos estudios que se presentan en la Reunión científica anual del ACAAI de este año muestran que la mayoría de las personas que piensan que tendrán una reacción alérgica, o que creen que han tenido una respuesta alérgica a la primera vacuna, pueden recibir todas las dosis de la vacuna de forma segura.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que, aunque el 58 % de los encuestados informaron de que su médico de atención primaria (PCP) les habló sobre la incorporación temprana del cacahuate, solo el 40 % de los padres dijo haber recibido una recomendación de incorporar el cacahuate antes de los 11 meses de edad.
A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals Latinos with asthma were 4.6 times more likely than Blacks to develop asthma exacerbations (uncontrolled asthma) following COIVD-19, and 2.9 times more likely than whites.
A new study being presented at this year’s ACAAI Annual Scientific Meeting showed the majority of pregnant women with a penicillin allergy label who were tested were not allergic and could tolerate penicillin during labor.
A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals that although 58% of those surveyed reported their primary care physician discussed early peanut introduction, only 40% of the parents said they received a recommendation to introduce peanut by 11 months of age.
Two new studies being presented at this year’s ACAAI Annual Scientific Meeting show most people who think they will have an allergic reaction, or who believe they have had an allergic response to the first vaccine, can safely be fully vaccinated.
A new study being presented at this ACAAI Annual Scientific Meeting reveals that most young adults surveyed did not receive sufficient transition preparation from their pediatric asthma providers.
CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.
In a newly published study, researchers at the University of Maryland School of Medicine have detected antibodies primarily made in response to infections in the mucous membranes — in such areas as the lungs, intestines, or vagina — in study participants with malaria.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination. The study findings have been published in the Annals of Internal Medicine.
A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.
Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.
There is no evidence that Fauci knowingly gave false information when asked about the NIH funding of " gain-of-function research" when it comes to the coronavirus. In fact, the letter itself notes that the viruses used in the experiments are “decades removed from SARS-CoV-2 evolutionarily” and that they “could not have been the source of SARS-CoV-2.”
A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.
The contributors are Kazan Federal University, Kazan State Medical Academy, Thapar Institute of Engineering and Technology, and the University of Liverpool.
A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.
Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.
Scientists from RUDN, National Medical Research Centre for Hematology and Lomonosov Moscow State University have uncovered one of the possible pathogenetic mechanisms of the severe lymphopenia in patients with COVID-19. For the first time, they presented evidence of the possibility of direct infection of lymphocytes with SARS-CoV-2 virions.
Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published today in the Journal of Clinical Investigation.
In pregnant women who tested positive for SARS-CoV-2, the virus that causes COVID-19, male placentas demonstrated significantly higher levels of certain genes and proteins associated with increased immune activation compared with female placentas, according to a new study published in Science Translational Medicine.
THE antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.
Have you ever experienced a stressful time in your life and then caught a cold, or wondered why you feel sad and depressed when you’re sick? It turns out that it’s not all in your head. Recent research spanning the fields of neuroscience and immunology suggests that when the brain senses a threat in the environment—whether it be physical, psychological, or social—it sends signals via a complex network of peripheral nerves that mobilize the immune system, readying it to protect us from injury.
New research has revealed that red blood cells function as critical immune sensors by binding cell-free DNA, called nucleic acid, present in the body’s circulation during sepsis and COVID-19, and that this DNA-binding capability triggers their removal from circulation, driving inflammation and anemia during severe illness and playing a much larger role in the immune system than previously thought. Scientists have long known that red blood cells, which are essential in delivering oxygen throughout the body, also interacted with the immune system, but didn’t know whether they directly altered inflammation, until now. The study, led by researchers at the Perelman School of Medicine at the University of Pennsylvania, was published today in Science Translational Medicine.
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine congratulates Treasurer Nancy Kopp on her five decades of public service, including since 2002, as the Maryland State Treasurer.
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in Cancer Cell in October.
Circadian clocks, which regulate most of the physiological processes of living beings over a rhythm of about 24 hours, are one of the most fundamental biological mechanisms. By deciphering the cell migration mechanisms underlying the immune response, scientists from the University of Geneva (UNIGE), in Switzerland, and the Ludwigs-Maximilians University (LMU), in Germany, have shown that the activation of the immune system is modulated according to the time of day.
The severe outbreak of COVID-19 in Delhi, India, in 2021 showed not only that the Delta variant of SARS-CoV2 is extremely transmissible but that it can infect individuals previously infected by a different variant of the coronavirus, say a team of international scientists writing in Science.
Over a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder. They now report that the effects of the therapy appear to be long-lasting, with 90% of patients who received the treatment eight to 11 years ago still disease-free.
ROCHESTER, Minn. — While people know their health affects their longevity and quality of life, many struggle to do even the small things that will help them live younger longer. Stephen Kopecky, M.D., a preventive cardiologist at Mayo Clinic, shares his insights on protecting overall health and boosting the immune system from his book, "Live Younger Longer: 6 Steps to Prevent Heart Disease, Cancer, Alzheimer's and More." Dr. Kopecky is a two-time cancer survivor.
A team of South Dakota State University chemistry researchers uncovered how cancer cells utilize a simple sugar residue to disguise themselves from the immune system. What they learned will help scientists develop more effective cancer therapeutics.
Researchers at Washington University School of Medicine in St. Louis have discovered that the viral protein NS1 from respiratory syncytial virus (RSV) alters the activity of immune genes, sabotaging the immune response to RSV infection.
A team at the Department for Pharmaceutical Sciences developed a therapy concept that could stop tumor growth.The immune system protects the body from cancer. To protect healthy body cells from its own immune system, they have developed a protective shield: the protein CD47 is a so called "don’t eat me" signal, which tells the immune cells to stand back.
Atopic diseases, which include eczema, allergic rhinitis, asthma, and food allergy, are closely linked to allergies against airborne particles, such as pollen, dust, mold, or animal dander, or foodstuffs like peanut, milk, soy, shellfish, or wheat.
The New York Stem Cell Foundation’s (NYSCF) 16th Annual Conference – held virtually on October 19-20 – convenes global leaders in stem cell research to present their latest progress towards new treatments and cures for the most devastating diseases and injuries in the world.
Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include promising clinical results for therapies targeting HER2, FGFR and TGF- β, discovering new drivers of lung cancer development, novel approaches to predict immune responses and overcome immunotherapy resistance, and a novel combination therapy for prostate cancer.
In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.
Two new studies presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how antibodies against the SARS-CoV-2 virus can vary among recipients of different COVID-19 vaccines and naturally infected individuals. The findings provide critical data about the immune response to COVID-19 vaccines that could inform future diagnostic research and vaccination efforts.
UChicago Medicine physician-scientists aimed to find out how the immune systems of children with a type of cancer called neuroblastoma respond to tumors. The answer to this question could help guide the treatment of pediatric patients.
The University of Kent’s School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified a protein that may critically contribute to severe forms of COVID-19.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates. The new research will guide the development of more effective COVID-19 antibody therapies and help scientists develop effective vaccines to address emerging viral variants.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
